Impact of propofol sedation versus opioid/benzodiazepine sedation on colonoscopy outcomes: a systematic review with meta-analysis

Abstract

Background and study aims Choice of sedation (propofol vs opioid/benzodiazepine) has been studied in the literature and has shown variable outcomes. The majority of recent studies have evaluated propofol sedation (PS) versus opioids, benzodiazepines, or a combination of both. We performed a systematic review and meta-analysis of studies comparing PS to other sedation methods to assess the impact on colonoscopy outcomes.

Methods Multiple databases were searched and studies of interest were extracted. Primary outcome of the study was adenoma detection rate (ADR) and secondary outcomes included polyp detection rate (PDR), advanced adenoma detection rate (AADR), and cecal intubation rate (CIR).

Results A total of 11 studies met the inclusion criteria with a total of 177,016 patients (148,753 and 28,263 in the opioids/benzodiazepine group and PS group, respectively). Overall, ADR (RR: 1.07, 95 % CI 0.99–1.15), PDR (RR: 1.01, 95 % CI 0.93–1.10), and AADR (RR: 1.17, 95 % CI 0.92–1.48) did not improve with the use of PS. The CIR was slightly higher for propofol sedation group (RR 1.02, 95 % CI 1.00–1.03).

Conclusion Based on our analysis, PS and opioid/benzodiazepine sedation seem to have comparable ADR. Our results do not favor use of a particular sedation method and the choice of sedation should be individualized based on patient preference, risk factors and resource availability.

Publikationsverlauf

Eingereicht: 29. Oktober 2019

Angenommen: 02. Januar 2020

Artikel online veröffentlicht:
25. Mai 2020

• References

• 1 Metwally M, Agresti N, Hale WB. et al. Conscious or unconscious: The impact of sedation choice on colon adenoma detection. World J Gastroenterol 2011; 17: 3912-3915
• 2 Borg BB, Gupta NK, Zuckerman GR. et al. Impact of obesity on bowel preparation for colonoscopy. Clin Gastroenterol Hepatol 2009; 7: 670-675
• 3 Rex DK, Cutler CS, Lemmel GT. et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28
• 4 Rex DK, Petrini JL, Baron TH. et al. Quality indicators for colonoscopy. Gastrointest Endoscopy 2006; 63: S16-S28
• 5 Lim S, Lee OH, Yoon IJ. et al. Moderate versus deep sedation in adults undergoing colonoscopy: systematic review and meta-analysis. Curr Med Res Opin 2019; 35: 879-885
• 6 Baker FA, Mari A, Amarney K. et al. Propofol sedation in colonoscopy: from satisfied patients to improved quality indicators. Clin Exp Gastroenterol 2019; 12: 105-110
• 7 Anderson JC, Weiss JE, Goodrich M. et al. Tu1719 does propofol use affect colonoscopy outcomes? Data from New Hampshire Colonoscopy Registry. Gastrointest Endosc 2012; 75
• 8 Hsieh Y-H, Tseng C-W, Hu C-T. et al. Prospective multicenter randomized controlled trial comparing adenoma detection rate in colonoscopy using water exchange, water immersion, and air insufflation. Gastrointest Endosc 2017; 86: 192-201
• 9 Lin OS, Selva DL, Kozarek RA. et al. One year experience with computer-assisted propofol sedation for colonoscopy. World J Gastroenterol 2017; 23: 2964-2971
• 10 Nakshabendi R, Berry AC, Munoz JC. et al. Choice of sedation and its impact on adenoma detection rate in screening colonoscopies. Ann Gastroenterol 2016; 29: 50-55
• 11 Thirumurthi S, Raju GS, Pande M. et al. Does deep sedation with propofol affect adenoma detection rates in average risk screening colonoscopy exams?. World J Gastrointest Endosc 2017; 9: 177-182
• 12 Turse EP, Dailey FE, Bechtold ML. Impact of moderate versus deep sedation on adenoma detection rate in index average-risk screening colonoscopies. Gastrointest Endosc 2019; 90: 502-505
• 13 Wang A, Hoda KM, Holub JL. et al. Does Level of Sedation Impact Detection of Advanced Neoplasia?. Dig Dis Sci 2010; 55: 2337-2343
• 14 Kochar R, Guturu P, Soloway RD. et al. Su1494 Moderate sedation compared with anesthesiology administered propofol sedation in polyp and adenoma detection during screening colonoscopy. Gastrointest Endosc 2012; 75
• 15 Venugopal K, Pearce CB. Colonoscopy with propofol sedation: better for the patient and for the endoscopist. J Gastroenterol Hepatol 2011; 26 (Suppl. 04) 22-33
• 16 Higgins J, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
• 17 Shuster J. Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, Editors. Res Synth Methods 2011; 2: 126-130
• 18 Higgins J, Altman D, Gotzsche P. et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928-d5928
• 19 Deeks J, Dinnes J, D'Amico R. et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7: iii-x, 1–173
• 20 Padmanabhan A, Frangopoulos C, Shaffer LET. Patient satisfaction with propofol for outpatient colonoscopy: a prospective, randomized, double-blind study. Dis Colon Rectum 2017; 60: 1102-1108
• 21 Radaelli F, Meucci G, Sgroi G. et al. Italian Association of Hospital Gastroenterologists (AIGO). Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008; 103: 1122-1130
• 22 Pace D, Borgaonkar M. Deep sedation for colonoscopy is unnecessary and wasteful. CMAJ 2018; 190: E153-E154
• 23 Rex DK, Overley C, Kinser K. et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol 2002; 97: 1159-1163
• 24 Rex DK, Heuss LT, Walker JA. et al. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 2005; 129: 1384-1391
• 25 Bielawska B, Hookey LC, Sutradhar R. et al. Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury. Gastroenterology 2018; 154: 77-85
• 26 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803